Filing
Spy
Filing
Spy
Home
About
GILD
Gilead Sciences, Inc.
Biopharmaceutical company
CUSIP: 375558103
Healthcare
US
6 holders
Ownership
Activity
Fundamentals
2015 Q1
44 of 52 quarters
Total Value
$151.00M
Total Shares
1.54M
Net Share Change
-906.2K
Activity
3 buying
3 selling
Investor
Value
Shares
Weight
Change
Egerton Capital
$77.56M
790.4K
1.1%
TRIM
-366.4K
(-31.7%)
Egerton Capital
$77.56M
790.4K shares
TRIM
-366.4K
(-31.7%)
Miller Value Partners
$52.90M
539.1K
1.8%
TRIM
-149.6K
(-21.7%)
Miller Value Partners
$52.90M
539.1K shares
TRIM
-149.6K
(-21.7%)
Matrix Asset Advisors
$17.28M
176.1K
2.0%
ADD
+119.2K
(+209.4%)
Matrix Asset Advisors
$17.28M
176.1K shares
ADD
+119.2K
(+209.4%)
Bridgewater Associates LP
$2.48M
25.2K
0.0%
TRIM
-512.1K
(-95.3%)
Bridgewater Associates LP
$2.48M
25.2K shares
TRIM
-512.1K
(-95.3%)
Jensen Investment Management
$519.0K
5.3K
0.0%
ADD
+30
(+0.6%)
Jensen Investment Management
$519.0K
5.3K shares
ADD
+30
(+0.6%)
Maverick Capital
$260.0K
2.6K
0.0%
NEW
Maverick Capital
$260.0K
2.6K shares
NEW
GILD — Gilead Sciences, Inc. - FilingSpy